Cellmid 2018 Annual Report 19

Non-audit services

The Group may decide to employ the auditor on assignments additional to their statutory audit duties where the auditor’s

expertise and experience with the Group is important and relevant where the nature of the services provided does not

compromise the general principles relating to auditor independence in accordance with APES 110: Code of Ethics for

Professional Accountants set by the Accounting Professional and Ethical Standards Board. There were no additional services

provided by the auditor during the year.

Meetings of Directors

Seven meetings of the Directors were held during the ﬁnancial year. Attendances by each Director during the year were as follows:

Shares under option

Unissued ordinary shares of the Company under option at the date of this report are as follows:

*On 23 November 2017, the Group completed the twenty to one shares consolidation.

400,000 shares are vested and held in escrow at 30 June 2018 (8,000,000 held in escrow in 2017). 1,440,000 options lapsed

during the ﬁnancial year ended 30 June 2018 (263,148,229 in 2017) and 1,025,000 options have lapsed since the end of the

ﬁnancial year to the date of this report.

Expiry date Exercise Price Number under option

Unlisted options 19 November 2018 $1.20 450,000

Unlisted options 19 November 2018 $0.62 25,000

Unlisted options 31 October 2019 $0.60 100,000

Unlisted options 1 July 2020 $0.60 50,000

625,000*

Directors’ Meetings Audit and Risk Nomination and

Committee Remuneration Committee

Number Number Number Number Number Number

eligible to attended eligible to attended eligible to attended

attend attend attend

Dr David King 7 7 6 6 1 1

Ms Maria Halasz 7 7 - 6 - 1*

Mr Bruce Gordon 7 7 6 6 1 1

Dr Fintan Walton 7 7 4 6^ 1 1

Dr Martin Cross 5 5 4 4 - -

Mr Dennis Eck 2 2 - - - -

* by invitation

^attendance as a member and by invitation